Evidence map›Paper›PMID 36557011›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Peri-Neural Invasion Is an Important Prognostic Factor of T2N0 Oral Cancer.

Chi-Sheng Cheng, Chien-Chih Chen, Yi-Chun Liu, Chen-Chi Wang, Yu-Shu Chou

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chi-Sheng ChengDepartment of Oral and Maxillofacial Surgery, Taichung Veterans General Hospital, Taichung 407219, Taiwan, China.
Chien-Chih ChenDepartment of Radiation Oncology, Taichung Veterans General Hospital, Taichung 407219, Taiwan, China.ORCID 0000-0001-6508-6448
Yi-Chun LiuDepartment of Radiation Oncology, Taichung Veterans General Hospital, Taichung 407219, Taiwan, China.
Chen-Chi WangDepartment of Audiology and Speech-Language Pathology, Asia University, Taichung 407219, Taiwan, China.ORCID 0000-0002-5934-724X
Yu-Shu ChouDepartment of Nuring, Taichung Veterans General Hospital, Taichung 407219, Taiwan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MATERIALS AND

methodsFrom January 2012 to December 2017, the data of 166 pathologically proven T2N0 oral cancer patients proved by radical surgery were retrospectively collected. The clinical and pathologic factors including age, gender, tumor differentiation grade, perineural invasion (PNI), angiolymphatic invasion (ALI), margin status, and adjuvant therapy were analyzed by univariate and multivariate analysis to determine their association with disease-specific survival (DSS), and disease-free survival (DFS), which were calculated by Kaplan-Meier method.

resultsAfter median follow up time of 43.5 months, overall 3-year rates of DSS and DFS were 86.1% and 80.1% respectively for our 166 patients. Univariate analysis showed that the 3-year DSS of 90.8% for PNI negative patients was significantly better than DSS of 57.0% for PNI positive patients (

conclusionPNI was an independent prognostic factor for T2N0 oral cancer patients. Adjuvant chemotherapy and radiotherapy may benefit the survival of this specific disease entity, but further investigations are needed to elucidate the optimal regimen.

Indexed as

Carcinoma, Squamous CellMouth NeoplasmsHumansNeoplasm InvasivenessNeoplasm Recurrence, LocalNeoplasm StagingPrognosisRetrospective Studiesadjuvant therapyangiolymphatic invasionchemotherapyoral cancerperineural invasionradiotherapysquamous cell carcinoma

Identifiers

PMID36557011
PMCPMC9787494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.